Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0000950170-24-069310

Principal Accounting Officer sold 1,207 shares at $4.04 ($4,876)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dunn Edmund Principal Accounting Officer 2024-06-03 Sale −1,207 $4.04 $4,876 15,554 D
Open-market sales · 1,207 sh · avg $4.04 · $4,876
Loading xslF345X05/ownership.xml…